CV6 Therapeutics raises $9.2M to test cancer drug
CV6 Therapeutics has secured $9.2m to progress its lead oncology asset into a first-in-human phase 1a clinical trial.
Source: labiotech.eu
Page 2 - Robert Ladner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robert Ladner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robert Ladner Today - Breaking & Trending Today